Peripheral Vascular Intervention Devices Market Global Report 2026

The peripheral vascular intervention devices market size has grown strongly in recent years. It will grow from $11.97 billion in 2025 to $12.97 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing prevalence of peripheral artery disease and vascular disorders, growing adoption of minimally invasive surgical procedures, expanding geriatric population with vascular complications, growth in hospital catheterization laboratory infrastructure, rising awareness of early diagnosis and vascular treatment.

The peripheral vascular intervention devices market size is expected to see strong growth in the next few years. It will grow to $18.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for image-guided interventional procedures, increasing adoption of drug-coated and bioresorbable vascular devices, growth in outpatient and ambulatory vascular treatment settings, expansion of personalized vascular disease management approaches, and continuous innovation in catheter-based intervention technologies. Major trends in the forecast period include AI-guided image-assisted peripheral vascular interventions for precision treatment, increasing adoption of minimally invasive endovascular procedures, wider use of drug-eluting and bioabsorbable vascular devices, growth in advanced atherectomy and plaque modification technologies, and expansion of catheter-based vascular disease management solutions.

The increasing prevalence of diabetes is expected to drive the growth of the peripheral vascular intervention devices market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from the body’s inability to produce or effectively utilize insulin. The rising incidence of diabetes is primarily fueled by sedentary lifestyles and unhealthy dietary patterns, as reduced physical activity and high-calorie food intake contribute to obesity, a major risk factor that significantly accelerates the onset and progression of the condition. The growing burden of diabetes increases the demand for peripheral vascular intervention devices, as the disease causes progressive damage to blood vessels, leading to peripheral artery disease and critical limb ischemia, which often require endovascular procedures to restore proper blood circulation. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the peripheral vascular intervention devices market.

Key companies operating in the peripheral vascular intervention devices market are focusing on developing advanced endovascular treatment solutions, such as peripheral support catheters, to enhance vessel patency, improve procedural outcomes, and support minimally invasive treatment of peripheral artery disease. Peripheral support catheters are medical devices designed to provide guidewire support and improved navigation during peripheral vascular procedures, helping physicians access complex blood vessels and accurately deliver therapeutic devices. For example, in December 2024, Terumo Interventional Systems, a US-based medical device company, launched the R2P NaviCross catheter, a peripheral support catheter. It is designed to support improved cross-ability and procedural efficiency in complex vascular cases. The device enables enhanced navigation through challenging lesions, improved device support, and greater flexibility in peripheral interventions, strengthening clinical outcomes in endovascular treatments.

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. Through this acquisition, Abbott seeks to enhance its peripheral vascular intervention portfolio by incorporating CSI’s atherectomy systems used in the treatment of peripheral and coronary artery disease, thereby broadening its minimally invasive cardiovascular treatment capabilities. Cardiovascular Systems, Inc. is a US-based medical device company that manufactures peripheral vascular intervention devices.

Major companies operating in the peripheral vascular intervention devices market are Medtronic plc, Boston Scientific Corporation, Becton Dickinson and Company (BD), Abbott Laboratories, Koninklijke Philips N.V., Terumo Corporation, Penumbra Inc., Shockwave Medical Inc., Cook Medical LLC, Inari Medical Inc., Cordis Corporation, Merit Medical Systems Inc., B. Braun Melsungen AG, Teleflex Incorporated, Asahi Intecc Co. Ltd., MicroPort Scientific Corporation, AngioDynamics Inc., Zylox-Tonbridge Medical Technology Co. Ltd., Bioteque Corporation, Avinger Inc., Cardio Flow Inc.

North America was the dominant region in the peripheral vascular intervention devices market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in peripheral vascular intervention devices report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral vascular intervention devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral vascular intervention devices market consists of sales of vascular access sheaths, occlusion catheters, and thrombectomy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The peripheral vascular intervention devices market research report is one of a series of new reports that provides peripheral vascular intervention devices market statistics, including peripheral vascular intervention devices industry global market size, regional shares, competitors with a peripheral vascular intervention devices market share, detailed peripheral vascular intervention devices market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral vascular intervention devices industry. This peripheral vascular intervention devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.